Next Article in Journal
An Explorative Investigation of the Flat-Jack Test for Prestress Assessment in Post-Tensioned Concrete Structures
Previous Article in Journal
Ensemble Method of Triple Naïve Bayes for Plastic Type Prediction in Sorting System Automation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Cascading Delphi Method-Based FMEA Risk Assessment Framework for Surgical Instrument Design: A Case Study of a Fetoscope

by
Wipharat Phokee
1,
Sunisa Chaiklieng
2,
Pornpimon Boriwan
3,
Thanathorn Phoka
4,5,
Jeroen Vanoirbeek
6 and
Surapong Chatpun
1,*
1
Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Songkhla, Thailand
2
Department of Occupational Safety and Environmental Health, Faculty of Public Health, Khon Kaen University, Khon Kaen 40002, Khon Kaen, Thailand
3
Department of Mathematics, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Khon Kaen, Thailand
4
Department of Computer Science and Information Technology, Faculty of Science, Naresuan University, Phitsanulok 65000, Phitsanulok, Thailand
5
Center of Excellence in Nonlinear Analysis and Optimization, Naresuan University, 99 Village No. 9, Tha Pho, Muang District, Phitsanulok 65000, Phitsanulok, Thailand
6
Department of Public Health and Primary Care, KU Leuven, 3000 Leuven, Belgium
*
Author to whom correspondence should be addressed.
Appl. Sci. 2025, 15(11), 6203; https://doi.org/10.3390/app15116203
Submission received: 14 April 2025 / Revised: 27 May 2025 / Accepted: 29 May 2025 / Published: 30 May 2025

Abstract

Featured Application

Risk assessment for medical device design.

Abstract

Failure Mode and Effect Analysis (FMEA) is crucial for identifying risk reduction opportunities in design. This study aims to aid in the design of sophisticated medical devices by setting guidelines and addressing weaknesses in data collection and risk priority numbers (RPNs). This is achieved by developing an FMEA framework with potential efficiency and efficacy benefits for design engineers, surgeons and patients. The FMEA framework covered risk analysis and risk evaluation by integrating a cascading Delphi method to address data collection and Multi-Criteria Decision-Making (MCDM) technique to address RPN calculations. This study involved the design of a flexible fetoscope for minimally invasive fetal intervention, analyzing and evaluating risks. The cascading FMEA framework had two stages for data collection, namely risk identification by individual interview and risk evaluation by individual email. The cascading Delphi FMEA framework with MCDM identified the potential risks for the mother at the tip (risk score = 0.927) and subsequent risks such as debris loss (risk score = 0.896), material degradation (risk score = 0.896), and glue dislodging (risk score = 0.896) as critical issues. By identifying failure modes early, medical device designers can better mitigate risks during the initial design stages.

1. Introduction

Patient safety is the most important priority in the intricate and resource-intensive process of designing medical devices [1,2,3]. Finding safety flaws later in the development process can cause a significant impact on the structural integrity of the device, worker safety, and patient welfare [4,5]. Risk assessment is critical in the design and development process of advanced medical devices to improve patient safety and reduce adverse medical events [1,2,3]. Implementing risk analysis during the initial design stage can reduce the cost and operational complexities associated with subsequent device redesign [4]. Risk assessment should be applied during the initial conceptual and design stages [6].
Failure Mode and Effect Analysis (FMEA) has been used for the medical device industry to analyze risk [7], but its use within the medical device design paradigm is still intrinsically complicated and challenging. ISO 14971 recommends FMEA as a risk assessment tool [4]. FMEA is in origin an engineering industry technique now also used to identify and analyze risks in healthcare products or equipment [8]. It has been adopted as a prospective method to reduce adverse medical events involving sophisticated equipment [9,10]. This method has been widely used both in initial design [6] and then later in the application, of medical devices and procedures [7]. This technique helps designers and engineers to understand risks by identifying and understanding the potential failure modes of the instrument or procedure [7].
The FMEA procedure is a highly effective technique relying on feedback provided by experts in a subjective approach. A multidisciplinary expert team is required to identify potential failure modes (FMs) [6]. FMEA expert team members’ dedication and agreement are crucial to an effective conclusion [11]. Attempts can be made to minimize undue subjective influences by changing from the experts’ subjective approach to a more objective one. FMEA has become increasingly popular and it is generally considered to be an appropriate and effective method for risk assessment in healthcare systems [9]. However, it has been noted to have several potential issues [12,13], two of which we consider critical: data collection and the calculation of the risk priority number (RPN).
The hazards in data collection are primarily potential group bias and time constraints. To collect data, several approaches were considered, including focus-group discussion [14], brainstorming sessions [15], interviews [16], observations, surveys [17], and related approaches [18]. Alternatively, the Delphi method has been used increasingly for collecting data [17]. The Delphi method is a sophisticated information-collecting technique that allows individuals to resolve complicated issues without having to meet in person [13,17]. The Delphi approach can handle vast amounts of data without group bias [13]. It is a group communication process designed to establish a consensus [7,13]. However, this technique has two drawbacks: it can take a long time and produce a poor response rate [17].
The RPN is calculated by multiplication of severity (S), probability of occurrence (O) and detectability (D) scores [6], with higher risk failures prioritized for corrective actions. However, several studies have raised concerns about the validity of this traditional approach, noting that multiplying three ordinal scales may distort risk rankings [19]. Furthermore, severity, occurrence, and detectability may not contribute equally—severity is typically regarded as most critical [20], while detectability is important for mitigation but generally considered less influential [20].
RPN scoring is subjective [7] and varies based on experts’ opinions [21], and this subjectivity introduces flaws such as equal weighting of S, O, and D, identical RPN values arising from different score combinations, and a failure to reflect the true relationships among factors and inherent uncertainty. In the healthcare context, FMEA struggles further with standardization and expert subjectivity. To resolve these limitations, Multi-Criteria Decision-Making (MCDM) methods, for example grey relational analysis (GRA), Technique for Order Preference by Similarity to Ideal Solution (TOPSIS), Analytic Hierarchy Process (AHP), and fuzzy logic, have been proposed [22].
A promising avenue for future research in this domain also involves an exploration of MCDM techniques aimed at enhancing the reliability of the RPN calculation [23]. To obtain the highest scores (quantitative data) of possible failure causes based on risk scores and severity score, MCDM was applied for calculating and prioritizing the risk scores to overcome traditional RPN calculation. In addition, Pareto theory and severity score were considered in selecting risk scores for corrective actions.
Fetoscopes are used to treat, among other conditions, twin-to-twin transfusion syndrome (TTTS). An unbalanced placental vascularization in the amniotic sacs of monochorionic (shared placenta) twins is one of the leading causes of mortality in the womb of monochorionic twins, especially through TTTS [24,25]. In severe cases of TTTS, fetoscopic laser ablation (FLA) has provided successful outcomes. This procedure, under ultrasound guidance, has become the gold-standard treatment over the last decade [24,25,26,27]. However, there are several issues that have arisen due to poor visibility, a limited field of view, the varying position of the placenta, the identification of blood vessels, occasional bleeding, and poor image quality [28,29,30]. Consequently, a new design of a fetoscope becomes a challenge, and risk assessment is necessary.
Currently, no standard method exists for assessing the risk of surgical instruments. The study aimed to propose a cascading Delphi framework designed to overcome FMEA limitations, specifically regarding data collection and RPN calculation using a case study of flexible fetoscope. The proposed framework systematically collects reliable expert insights.

2. Materials and Methods

The study proposed a framework to identify and evaluate the potential failure modes of the surgical instrument, the flexible fetoscope designed by an engineering team at KU Leuven, Belgium. We improved data-gathering for FMEA, using a cascading Delphi method, RPN calculation, and applying MCDM and uncertainty theory. The cascading Delphi framework provides qualitative and quantitative data. Content analysis techniques were examined for qualitative data including potential failure modes, potential failure effects, potential failure causes, and detectability.

2.1. Flexible Fetoscope

The proposed flexible fetoscope consists of 3 main parts: a handle, a flexible segment, and the tip, as shown in Figure 1. The handle is an ergonomically designed non-conductive pistol grip with a slider to operate the flexible segment. The slider is moved by the surgeon’s thumb to bend the flexible segment. A McKibben actuator inside the handle is operated by pneumatic pressure from an external air supply. A wire transmits the force from the McKibben actuator to bend the flexible segment.
An electrical connection for the actuator and camera is set on the end of the handle. The laser fiber and water irrigation systems are as in the current version. The flexible segment is 3 cm long, has a 3 mm diameter, and can bend up to 90°. The tip contains three channels for a light source, a camera, and the working channel. The light-emitting diode (LED) light source is external to the fetoscope, and the light is transmitted by optical fiber to the tip. The camera is of better quality than the current versions, with higher resolution and better image quality. The working channel carries water irrigation and the laser fiber to coagulate the placental vessels. A medical-grade epoxy adhesive is used to fix and seal all components in the tip. The new parts and components of the flexible fetoscope was adapted from Ahmad et al. [28] as shown in Figure 1.

2.2. FMEA Expert Team

We initially employed purposive sampling by directly reaching out to known individuals in each target group. For obstetric surgeons, recruitment started with the head of the Fetal Therapy Center in Thailand, who then recommended other qualified surgeons from university hospitals in Thailand. This process was further supported by referrals among participants, effectively creating a limited snowball sampling framework. For engineering aspect, the head of research group working on medical device design at KU Leuven, Belgium, invited engineers who have experience in fetoscopes.
Data were collected from 11 experts, consisting of 6 engineers from KU Leuven, Belgium, and 5 obstetric surgeons from three university hospitals in Thailand. This cohort covered the essential disciplines and stakeholders such as designers, engineers, and users. Due to the need for specific knowledge and experience, snowball sampling was used in this study. Snowball sampling creates a network of participants by finding one or two participants and then asking them to identify additional experts when direct recruitment is challenging. This method is suitable for participants with specific knowledge and experience, when it is difficult to locate or contact experts on the topic.
All selected experts have knowledge of and experience with fetoscopes. The experts were asked to register by Google Forms to provide relevant personal information and work experience details. Before data collection, online initial meetings were held in two rounds for six engineers from KU Leuven and five Thai obstetric surgeons to explain the process, their roles, and the objectives of the study. Online individual interview by Zoom was used for an initial meeting and risk identification, and email conversations for subsequent rounds.

2.3. The Conceptual Framework of a Cascading Delphi Method

The framework proposed in this study was divided into five stages: preparation, Delphi-1 (risk identification), Delphi-2 (risk analysis), the calculation of S, O, and D (risk evaluation), and the compilation of a final report as presented in Figure 2. Each stage had several steps to complete the task. The conceptual framework of a cascading Delphi method approach to data collection for advanced surgical instrument, adapted from Sobaih et al. [31], as shown in Figure 2.
  • Stage 1: Preparation: to set the scene for the experts
Step 1. Choosing the device/instrument: a virtual prototype of flexible fetoscope and a clear description of the instrument were explained to the expert team.
Step 2. Building the FMEA expert team: the facilitator chose participants with prior experience and knowledge of the type of instrument being studied, and willingness to provide feedback.
Step 3. Meeting the FMEA expert team: the facilitator explained the objectives, FMEA, the process and their responsibilities to participating experts.
  • Stage 2: Delphi-1: to identify the relevant failure modes (FMs)
Step 4. Analyzing the different parts and functions of the device/instrument online: the participants were presented with the figure of flexible fetoscope and an open-ended question (“What are the new parts of the fetoscope, analyzed by function?”) during an individual online interview.
Step 5. Identifying potential failure modes (FMs) online: the experts were asked an open-ended question (“What could possibly go wrong with which parts of the fetoscope in terms of the patients and fetuses?”) about the potential failure modes. Potential failure modes were listed.
Step 6. Preparing a summary of individual’s comments: the facilitator summarized separately each interview with the experts.
Step 7. Sending the report to the individual expert concerned for review and amendment as required: the facilitator reduced the possibility of error or facilitator bias by sending each expert the summary of his/her own interview, for review and amendment as necessary.
Step 8. Preparing the Delphi-1 summary: the facilitator prepared a summary report on the views of all experts together. The outcomes of all experts are combined by the facilitator. Because of different wording of the same failure, some identified failure modes were merged to a single one, effectively avoiding overlap. Content analysis and generative AI (Claude) were applied to analyze qualitative data in this step. The generative AI (Claude) was used to generate new content of potential failure modes from all experts.
  • Stage 3: Delphi-2: to analyze causes, effects, and detectability and provide scores for S, O, and D
Step 9. Analyzing potential failure causes, failure effects, detectability, and providing scores for each failure mode: the experts were asked open-ended questions to list the potential failure effects (“What would the consequences be of a particular failure?”), failure causes (“Why would this failure occur?”), and detectability (“What is the potential to detect failures and intervene in time?”).
Two patient safety risk areas—namely, those concerning mother and fetus(es)—were considered when identifying failure effects. The experts provided input via email, and they were asked to score each potential failure mode for severity (S), probability of occurrence (O), and detectability (D). Each potential failure mode (FM) could be associated with more than one potential failure effect. Therefore, one failure mode could generate more than one potential failure cause (FC). To search for the root causes, each FC was taken into account to calculate a risk score.
As in Table 1, the severity rating for the mother and surgeon is on a scale of 1–7, with 1 indicating no injuries and 7 indicating death. The grading system is based on the Clavien–Dindo classification for surgical complications [32,33].
As shown in Table 2, we assigned severity scores for the fetus(es) based on criteria established by the EVERREST International Adverse Event Consensus group, which gives a rating scale from 1 (low danger) to 5 (extremely dangerous) [32,33,34]. This judgment demonstrates how the lives of fetuses are given less weight.
Table 3 shows an incidence rating scale from 1 (very infrequent) to 5 (very frequent). This is in line with typical medical FMEA practice [33]. Unlike the severity scale, a single incidence scale may be utilized throughout. To make the scale more clear, quantitative probability estimates were added [33,35]. A rate of 1/10,000, for example, suggests that the danger is anticipated to occur in one out of every 10,000 surgical procedures, making the scale very low or extremely infrequent.
Detectability was assessed on a scale of 1 to 5, with 1 representing extremely high and 5 representing extremely low detectability as shown in Table 4 [32,33]. Remember that a high detectability score is given when the likelihood of finding a failure is low.
Step 10. Analyzing qualitative data by content analysis: the outcomes in this stage of all experts were combined and analyzed qualitatively by the facilitator. The facilitator applied content analysis and generative AI (Claude) to analyze qualitative data. The generative AI (Claude) was applied to group the contents of potential failure causes, failure effects, and detectability from all experts.
Step 11. Preparing the Delphi-2 summary: the facilitator summarized the Delphi-2 report which included potential failure causes, failure effects, and detectability for each FM.
  • Stage 4: Calculating RPN and prioritizing FCs: this stage was to process the numerical results as quantitative data for S, O, and D and to compute the risk scores. There are several methods of MCDM to improve the RPN calculation. This study applied hybrid MCDM methodology and uncertainty theories to overcome RPN calculation weaknesses. grey relational analysis (GRA) and Evaluation based on Distance from Average Solution (EDAS) are effective methods in MCDM for assessing and prioritizing risk factors in FMEA, particularly during the medical device design stage [12].
Step 12. Identifying and bringing together separate S, O, and D scores for each potential failure cause (FC): each possible cause of failure, after qualitative data analysis, was given S, O, and D scores provided by the experts in Step 9. MCDM was applied for RPN calculations, based on the product of the three risk factors—S, O, and D.
Step 13. Computing the risk scores based on MCDM and uncertainty theories: we calculated the risk scores for each FC using the hybrid approach proposed by Pintelon et al. [12], applying the Entropy method based on uncertainty theory to determine weights of the three factors: severity (S), probability of occurrence (O), and detection (D). The grey relational analysis method was used to assess the relationships between criteria and alternatives, making it suitable for situations involving uncertainty or limited data. It evaluated alternatives based on their grey relational degree, enabling the identification of significant failure modes through the analysis of S, O, and D. We revisited the calculation steps outlined by Pintelon et al. [12], along with the notations presented in the table of abbreviations, which was used throughout this work.
In the failure cause ranking methodology proposed by Pintelon et al. [12], four steps are outlined as follows:
(i)
To form a multidisciplinary team of experts, identify potential failure modes, and assess the relevant evaluation criteria.
(ii)
To determine the distinct weights of the three FMEA factors—severity (S), probability of occurrence (O), and detection (D)—we applied the Entropy method. This technique addresses a key limitation of conventional FMEA, which assumes equal importance for all factors and thus overlooks their context-dependent influence on overall risk.
The Entropy method begins by normalizing the decision matrix to calculate the proportional value z i j , as shown below:
z i j = x i j i = 1 n x i j
E j = 1 ln n . i = 1 n z i j   .   ln z i j  
d j   = 1 E j
ω j = d j j = 1 m d j
(iii)
To normalize the decision matrix using the vector normalization technique from the TOPSIS method to ensure comparability across criteria. After normalization, the Positive Ideal Solution (PIS) and Negative Ideal Solution (NIS) are derived by identifying the best and worst values for each criterion across all alternatives.
y i j = x i j j = 1 m x i j 2  
P I S j = m a x i y i j  
N I S j = m i n i y i j  
  • (iv) To further assess the relationship between each alternative and the ideal/worst solutions, Grey Relational Coefficients (GRCs) are calculated. These coefficients reflect how closely each alternative aligns with PIS and NIS. The distance between each normalized value and the PIS/NIS is first computed. Then, using these distances, the GRCs for both the best (positive) and worst (negative) references are determined. This step allows for the partial incorporation of inter-criteria relationships and is especially useful under uncertainty.
  i j +   = y i j   P I S j  
i j   = y i j   N I S j
  g i j = m   + ξ M + i j + + ξ M +
  v i j = m + ξ M i j + ξ M
G = g 11 g 1 m g n 1 g n m
  V = V 11 V 1 m V n 1 V n m
Step 14. Prioritizing the possible failure causes (FCs): this step follows the methodology proposed by Pintelon et al. [12] to prioritize the risk scores of each failure cause (FC). The Evaluation based on Distance from Average Solution (EDAS) method is applied to calculate appraisal scores. These scores reflect how far each alternative is from the average solution, considering both positive and negative deviations. The resulting scores are then used to rank the FCs according to their relative risk.
  A V j , b e s t = i = 1 n g i j n
  A V j , w o r s t = i = 1 n v i j n
P D A i j , b e s t = max 0 , g i j A V j , b e s t A V j , b e s t ; N D A i j , b e s t = max 0 , A V j , b e s t g i j A V j , b e s t
  P D A i j , w o r s t = max 0 , v i j A V j , w o r s t A V j , w o r s t ; N D A i j , w o r s t = max 0 , A V j , w o r s t v i j A V j , w o r s t
  S P i , b e s t = j = 1 m w j   P D A i j , b e s t ;   S N i , b e s t = j = 1 m w j   N D A i j , b e s t  
S P i , w o r s t = j = 1 m w j   P D A i j , w o r s t ;   S N i , w o r s t = j = 1 m w j   N D A i j , w o r s t  
N S P i , b e s t = S P i , b e s t   max S P i , b e s t ;   N S N i , b e s t = 1 S N i , b e s t max S N i , b e s t
N S P i , w o r s t = S P i , w o r s t   max S P i , w o r s t ;   N S N i , w o r s t = 1 S N i , w o r s t max S N i , w o r s t
A S i , b e s t = N S P i , b e s t   + N S N i , b e s t   2
A S i , w o r s t = N S P i , w o r s t   + N S N i , w o r s t 2
A S i = A S i , b e s t   + 1 A S i , w o r s t 2
The goal of FMEA is to find measures by implementing corrective actions to reduce risks. The potential FCs or risks which need to be mitigated must be identified. In healthcare FCs are prioritized according to risk and severity scores. The FCs with the highest risk scores would normally be given priority in FMEA, but in view of the paramount importance of patient safety, high severity scores are also prioritized. Then, Pareto theory (focusing on 20% risk scores) and severity scores were applied in selecting FCs. These combined rankings determine where risk mitigation efforts should focus.
  • Stage 5: Compilation of final report: summarizing the report.
Step 15. Compiling the final report: the results were summarized using the facilitator, who combined the Delphi-1 to Delphi-2 outcomes. This stage involved summarizing all results and providing critical reflection. The critical elements were identified for providing corrective actions to eliminate or mitigate possible FCs of the medical device.

3. Results

3.1. Framework Results

This study applied a cascading Delphi method for data collection in FMEA during the design phase of a flexible fetoscope. Stage 2 was conducted by means of individual online interviews, with a response rate of 100%. Experts spent 25–65 min (average 38 min) on this. Data collection in Stage 3 was more difficult. The experts spent 75–150 min (average 108 min) on this, with a response rate of 82%.

3.2. Expert Data

All obstetric surgeons have knowledge of and experience with fetoscopes for twin-to-twin transfusion syndrome (TTTS), more than 5 years. The largest group of experts were five medical teachers (45%), followed by four PhD students (37%), a postdoctoral researcher (9%) and a research engineer (9%). Furthermore, the experts’ specialization and experience are presented in Table 5.

3.3. Stage 2: Delphi-1 Result

Engineers (average 45 min) spent more time than surgeons (average 29 min) in this stage. In subsequent email follow-up, most experts (8 out of 11 or 73%) responded, and of those, 3 (27%) made corrections.
New parts of the flexible fetoscope, adapted from Ahmad et al. [28], were classified by the experts in three groups: handle, flexible segment, and tip. Additional components of the handle were identified by experts, including the slider, McKibben actuator, the wire transmitting force between the actuator and the tip, and the air supply, as shown in Figure 3. Furthermore, several new components of the flexible segment were additionally addressed, such as the bending part, laser fiber, the wire, electrical components and connections, and water irrigation. Similarly, new components were identified at the tip of fetoscope, including a camera, light source, wire, electrical components and connections, tube end sleeve, and glue.
Focusing on the patients’ safety (mother and fetus(es)), 26 potential failure modes were identified, with 13 (50%) related to the tip, 7 (27%) to the flexible segment, and 6 (23%) to the handle. There was a degree of consensus among the experts. Four potential failure modes were identified by more than 50% of them, namely excessive force on the wire (73%), an air leak within the handle (55%), damage to the camera at the tip (55%), and a glue overheating or melting (55%), as shown in Table 6.

3.4. Stage 3: Delphi-2 Result

In Stage 3: Delphi-2, there were two medical doctors who withdrew from the study, resulting in a participation rate of 82%. At this stage, only three experts responded to the form within one month. The remaining responses were delayed by four to seven months. The engineering experts were particularly dilatory, but responses were eventually forthcoming after face-to-face prompting became possible.
We found 26 potential failure modes (FMs) in total, based on 419 possible failure causes (FCs): 56% (234 FCs) were related to the tip, 30% (128 FCs) to the flexible segment, and 14% (58 FCs) to the handle. Some examples of data collected using the cascading Delphi FMEA method are shown in Table 7.
Multi-Criteria Decision Making (MCDM) was applied to address the weaknesses of RPN calculation. Based on the calculations in above equations, the weights for each factor—S, O, and D—are determined as shown in Table 8.
Risk scores were computed FCs based on MCDM and ranked (Step 13 and 14). On the (Pareto-like) assumption that the failure causes with the highest risk scores posed the greatest risks, the top 20% were examined further. Then, severity scores were applied in selecting FCs.
The highest risk scores found was for contamination resulting from manufacturing defects for the mother (ID = 3.8.1A3, risk scores = 0.927) followed by loss of particles (debris) from the tip during use inside the patient caused by assembly defects (ID = 3.7.2A1, risk scores = 0.896), material fatigue and degradation (ID = 3.7.2B6, risk scores = 0.896), dislodging of the glue from the tip caused by assembly defects (ID = 3.7.3A1, risk scores = 0.896) and material fatigue and degradation at the tip (ID = 3.7.3B5, risk scores = 0.896). The potential failure causes (FCs) with the 10 highest risk scores were associated with the tip of the flexible fetoscope, particularly glue-related issues such as cracking, dislodgement and particles loss (debris) and contamination of the entire fetoscope, as shown in Table 9.
The tip was the most frequently identified failure point (66%, with 69 FCs), primarily due to material fatigue and degradation (16 cases) and material defects (14 cases) which led to fluid contact with bare electrical components and connections at the tip. For the flexible segment, the failures were concerned (25%, with 26 FCs) with material defects (6 cases), assembly defect (6 cases) and material fatigue and degradation (5 cases) causing a leakage of irrigation fluid and contact with bare electrical wire at the flexible segment (15 cases). For the handle, the failures were concerned (9%, with 9 FCs) with excessive force or pressure issues (6 cases) on the wire at the McKibben actuator in the handle.

3.5. Sensitivity Analysis of Scenario Weights and Rank Stability

To evaluate the robustness of the ranking obtained by the hybrid approach proposed by Pintelon et al. [12], sensitivity analysis was conducted by testing four distinct weight configurations corresponding to different decision-maker emphasis on severity (S), occurrence (O), and detection (D). These weight vectors are:
  • – Scenario 1: (0.2, 0.2, 0.6)—emphasis on detection;
  • – Scenario 2: (0.2, 0.6, 0.2)—emphasis on occurrence;
  • – Scenario 3: (0.33, 0.33, 0.33)—equal weighting;
  • – Scenario 4: (0.6, 0.2, 0.2)—emphasis on severity.
The ranking results for each CF under these scenarios were compared using Kendall’s Tau correlation to access to assess the consistency of rankings across different weighting schemes. Kendall’s Tau is particularly suitable for this analysis, as it measures the ordinal association between ranked variables, making it ideal for evaluating the similarity of prioritizations derived from varying weighting strategies, without assuming any linear relationship between them [36].
Table 10 presents the Kendall’s Tau correlation coefficients, which quantify the consistency of rankings across different weighting scenarios. Among the scenarios, Scenario 3—which applies equal weighting to severity, occurrence, and detection—exhibits consistently high correlations with all other scenarios (τ ≥ 0.679), suggesting that a balanced approach results in stable and representative rankings of the CFs. The strongest agreement is observed between Scenario 1 and Scenario 3 (τ = 0.838), indicating that even when detection is emphasized, the resulting rankings remain closely aligned with those from a balanced weighting. Conversely, the lowest correlation occurs between Scenario 2 and Scenario 4 (τ = 0.439), a finding that aligns with the distinct emphasis each scenario places on different criteria—occurrence in Scenario 2 and severity in Scenario 4—which are likely to prioritize different CFs. Overall, the application of the hybrid approach proposed by Pintelon et al. [12] demonstrates moderate to strong rank stability across various decision-making preferences, confirming its robustness and adaptability for practical applications.

4. Discussion

The big challenge for FMEA during the early design phase is data collection, since the device does not physically exist. The experts have to make predictions based on their experience and knowledge [37]. Accordingly, it may be quite difficult to reach consensus. The proposed cascading Delphi method can generate valuable ideas from the experts. It is important that these ideas should be recognized, rather than being subjected to attempts to “erode” them away through consensus. The proposed cascading Delphi method is less time consuming than traditional FMEA and the traditional Delphi method as the experts can participate on their own schedules without a series of meetings.
Some aspects of the traditional Delphi method were modified to make it more efficient. One-on-one interactions, rather than group discussion, were used to avoid group bias. Additionally, the emphasis on reaching a consensus was reduced. The cascading Delphi method aims to reduce time consumption by using technology such as email and by relaxing the requirement for total consensus, instead aiming to maximize the number of potential failure modes identified. This study found that an individual interview was indeed productive in terms of collecting ideas and analysis because of the opportunity to ask detailed questions. After completing an individual interview, the experts reviewed their feedback as summarized by the facilitator, and each expert had the opportunity to review and edit their answers. Most experts took the opportunity to edit on most occasions, and some revised a given response more than once, which helped to reduce facilitator’s bias.
All potential failure modes (FMs) are examined in Stage 3: Delphi-2 to analyze and give scores for potential failure effects, causes, and detectability. This stage is demanding and time consuming. The experts are expected to give careful consideration to their comments and scores. Accordingly, some of the experts dropped out of the study altogether at this stage, while others were slow in responding. To minimize both effects, the facilitator in the cascading Delphi framework should, for example, provide clear instruction, easy-to-use forms, and full information from the start of the process. Qualitative data from Stage 3: Delphi-2 are more diverse than those from Stage 2: Delphi-1. This makes it more difficult to reach a consensus, especially regarding scores for severity (S), probability of occurrence (O), and detectability (D).
During the FMEA process, patience is essential when preparing data. Meetings play an important role by providing an opportunity to explain the research to all participants. If some experts cannot attend these meetings, individual sessions should be arranged for them. The facilitator can support the experts by developing user-friendly data collection forms and offering clear, straightforward guidelines on data preparation. Providing examples could also be especially helpful, particularly for the data preparation in Step 2, which is conducted via email.
Group members’ dedication and agreement are crucial to the effective completion of FMEA [11]. In an initial meeting between the facilitator and the experts, it is an opportunity for the facilitator to clearly explain the study’s objectives and methodology. The facilitator can get to know the other participants and make the experts more receptive to the questions put to them and thus make for better overall results. Individual interviews can be more time consuming for experts than answering questionnaires, because the individual interviews often involve detailed discussion. However, individual interviews are useful in improving the final outcome by eliciting detailed responses through in-depth questioning. In addition, in the proposed cascading Delphi method, all experts took part in all stages of the process, including reviewing and editing their opinions and comments at each stage. The traditional version of data collection for FMEA had three main drawbacks: group bias, time consumption, and sample size issues [38,39].
Snowball sampling is a suitable method for collecting data for research when experts are difficult to find. Snowball sampling creates a network of participants by finding one or two participants and then asking them to refer others. This method is suitable for participants with specific knowledge and experience when it is difficult to locate or contact experts on the topic. There does not appear to be a standard for the normal or minimum number of experts, but we believe that this cohort represents the essential disciplines and stakeholders, including designers, engineers, and users.
Establishing a team of FMEA experts is an important step, as FMEA is a subjective method that requires input from experts. Experts should be selected to include stakeholders who are involved as both producers and users with direct experience with the equipment or device to be studied, and from a variety of professions to provide a comprehensive perspective. The opinions of the experts should then be diverse, like a puzzle that fits together into a single picture.
Risk priority number (RPN) score is inherently often leading to variations due to differing opinions among teams. The exploration of Multi-Criteria Decision-Making (MCDM) techniques offers a significant advancement in improving reliability and overcoming the limitations of traditional RPN calculations. Conventionally, RPN scores in FMEA have relied on subjective assessments [7], which can lead to inconsistencies due to differing opinions among evaluators [21]. In contrast, MCDM techniques transform this process into a more objective methodology. By systematically integrating multiple criteria and considering the relationships and priorities among them, MCDM enhances the precision and consistency of the RPN assessment. This approach not only addresses the issue of equal weighting for severity, occurrence, and detection but also mitigates the variability arising from individual judgments. The adoption of MCDM techniques thus represents a promising step toward a more robust and reliable risk prioritization framework in FMEA.
Hybrid MCDM approaches, such as the combination of TOPSIS and GRA, are widely employed to address the limitations of the traditional RPN by generating additional priority indices and weighting criteria [12]. These methodologies enhance the analysis by considering a broader range of elements, effectively tackling key weaknesses of conventional approaches. However, it is important to note that MCDM-based FMEA approaches often remain context dependent and may lack robustness in situations characterized by incomplete information, particularly during the design phase of FMEA [12].
Using generative AI in the content analysis can facilitate the process and lead to highlighted risk areas requiring mitigation for a flexible fetoscope. In addition, utilizing generative AI as a copilot has the potential to reduce the time required by more than half and reduce the risk of occupational back pain.
There are several concerns in this study. First, the drop from 100% to 82% participation rate could reduce the diversity of expert opinions, introduce bias, weaken consensus, and affect the validity and consistency of final risk prioritization. These impacts are particularly significant given the small expert sample size. In this study, the limited sample size is due to the confidential nature of early fetoscope design and the need for reliable input from experts with direct, specialized knowledge and experiences. Second, delays of up to seven months in the Stage 3 response could skew the context of earlier discussions.
One way to address the weaknesses identified in this study is by ensuring that the facilitator must have in-depth knowledge and understanding of the equipment’s operation to be studied to be able to analyze the data more accurately. The editing process, which often involves multiple iterations between experts and facilitator, is a process which carries an intrinsic risk of facilitator bias, of which the facilitator must be conscious. Being aware of this risk is essential. The facilitator must be patient and have task-tracking skills. The facilitator must use both art and science in tracking data to maximize cooperation. Multiple communication channels will help in tracking data, especially face-to-face tracking. Good relationships between the research team and experts are very important in obtaining quality data and lowering the dropout rate.
Since the device to be studied is still in the design phase, it is vital that as much information as possible, including detailed drawings, mock-ups, and samples of components which may already exist, should be provided to the experts, either physically, or in the form of images or video clips. We found that experts often confused possible failure modes with possible causes of failure, so it is important to clarify this. Cost and environmental factors should be considered to cover the production of medical devices.
The cascading Delphi method-based FMEA framework, developed in alignment with ISO 14971, addresses risk management challenges for medical devices in the early design phase and applies to a variety of medical devices. The proposed framework could be applied to devices such as new endoscopes or minimal invasive surgical tools. For example, in patient’s safety aspect, similar failure causes and effects related to device’s components could be assessed using the same process. Our proposed framework was previously piloted using an electromagnetic self-tracking fetoscope before being refined and validated with a flexible fetoscope, allowing us to address how key steps can be generalized or adapted for other applications.
While the hybrid MCDM method applied in this study offers a structured and quantitative approach to prioritizing risk, alternative methods such as decision tree models integrated with fuzzy logic may provide additional flexibility and interpretability. These models are particularly useful when expert assessments are qualitative or expressed in linguistic terms. Future work may explore such methods to handle uncertainty in early-stage design even more effectively, allowing rule-based logic and fuzzy inference to complement the numerical analysis of risk.
Future research could add steps to reach consensus by sending expert reports for review both individually and as a group in each stage, but fatigue and impatience of experts must be taken into account. The analysis of qualitative data in Stage 3 was time consuming. Using machine learning or artificial intelligence tools can reduce the workload and save time; however, the facilitator must still collect data to obtain consistent, systematic, and verifiable qualitative data and scores.
This study involved only risk identification, risk analysis, and evaluating which risk scores are calculated and prioritized for potential FCs. High-risk FCs need to be analyzed by experts to provide corrective actions to mitigate or eliminate risks. Finally, the risk is re-evaluated after redesigning to verify that the interventions have effectively lowered it to an acceptable level.

5. Conclusions

In this study, the cascading Delphi framework with MCDM was applied to overcome FMEA weaknesses covering data collection (group bias and time constraints) and RPN calculation, using a flexible fetoscope as a case study. The cascading Delphi method could improve the effectiveness of data collection for risk management to reduce or prevent potential failures. The proposed cascading Delphi method could be utilized to gather data from different stakeholders, such as engineers and surgeons. A multidisciplinary expert team identified, analyzed and evaluated the risk in the design of a flexible fetoscope. The expert team could provide feedback freely without group bias, and at flexible times. Data collection was reliable because the experts could review and correct summaries of their feedback in each round. The results after applying FMEA with cascading Delphi method and MCDM showed that the highest RPN was contamination resulting from manufacturing defects for mothers. It is challenging to reduce the time consuming and increase the reliability of data collection. Furthermore, using high technology such as artificial intelligence can assist the laborious of content analysis.

Author Contributions

Conceptualization, W.P. and S.C. (Surapong Chatpun); methodology, W.P.; software, P.B. and T.P.; validation, W.P. and S.C. (Surapong Chatpun); formal analysis, W.P.; investigation, W.P.; resources, W.P.; data curation, W.P., P.B. and T.P.; writing—original draft preparation, W.P., P.B. and T.P.; writing—review and editing, S.C. (Surapong Chatpun), S.C. (Sunisa Chaiklieng) and J.V.; visualization, W.P.; supervision, J.V., S.C. (Sunisa Chaiklieng) and S.C. (Surapong Chatpun); project administration, W.P.; funding acquisition, W.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Royal Thai Government scholarship.

Institutional Review Board Statement

The study was conducted under the approval of the Human Research Ethics Committee (HREC), Faculty of Medicine, Prince of Songkla University (Number REC.64-494-25.2 and date of approval 12 October 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy.

Acknowledgments

The authors would like to give special acknowledgment to six engineers from KU Leuven, Belgium and five Thai obstetric surgeons from Siriraj Fetal Therapy Center (SiFTC), Prince of Songkla University, and Chiang Mai University. Additionally, we appreciated the insightful comments and suggestions for the preparation of this manuscript provided by Richard S. Henderson.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
S Severity
O Occurrence
D Detectability
i Index referring to the alternative
j Index referring to the criteria
x i j Element of initial decision matrix
z i j Element of Entropy normalization-matrix
E j Entropy
d j Degrees of variation
w j Weight of the j t h criterion
y i j Element of TOPSIS normalization matrix
P I S j   Positive ideal solution
N I S j   Negative ideal solution
i j + Distance since element y i j and relative P I S j  
i j Distance since element y i j and relative N I S j  
M + max j max i i j +
m + min j min i i j +
M max j max i i j
m min j min i i j
ξ Distinguishing coefficient
g i j Grey relational coefficient relative at P I S j  
v i j Grey relational coefficient relative at N I S j  
G Matrix of g i j
V Matrix of v i j
A V j , b e s t Average value relative G matrix
A V j , w o r s t Average value relative V matrix
P D A b e s t Positive distance to average calculated on best solution
N D A b e s t Negative distance to average calculated on best solution
P D A w o r s t Positive distance to average calculated on worst solution
N D A w o r s t Negative distance to average calculated on worst solution
S P i , b e s t Weighted sum of P D A b e s t for each alternative
S N i , b e s t Weighted sum of N D A b e s t for each alternative
S P i , w o r s t Weighted sum of P D A w o r s t for each alternative
S N i , w o r s t Weighted sum of N D A w o r s t for each alternative
N S P i , b e s t Normalized S P i , b e s t
N S N i , b e s t Normalized S N i , b e s t
N S P i , w o r s t Normalized S P i , w o r s t
N S N i , w o r s t Normalized S N i , w o r s t
A S i , b e s t Best-solution appraisal score
A S i , w o r s t Worst-solution appraisal score
A S i Overall appraisal score

References

  1. Bitkina, O.V.; Kim, H.K.; Park, J. Usability and User Experience of Medical Devices: An Overview of the Current State, Analysis Methodologies, and Future Challenges. Int. J. Ind. Ergon. 2020, 76, 102932. [Google Scholar] [CrossRef]
  2. Garro, F.; McKinney, Z. Toward a Standard User-Centered Design Framework for Medical Applications of Brain-Computer Interfaces. In Proceedings of the 2020 IEEE International Conference on Human-Machine Systems, ICHMS 2020, Rome, Italy, 7–9 September 2020; pp. 4–6. [Google Scholar] [CrossRef]
  3. Marešová, P.; Klímová, B.; Honegr, J.; Kuča, K.; Ibrahim, W.N.H.; Selamat, A. Medical Device Development Process, and Associated Risks and Legislative Aspects-Systematic Review. Front. Public Health 2020, 8, 308. [Google Scholar] [CrossRef] [PubMed]
  4. Mishra, S.; Shukla, V.K. Latest Risk Management Guideline (ISO 14971:2019) & Environmental Aspects of Medical Device. Int. J. Drug Regul. Aff. 2020, 8, 15–24. [Google Scholar] [CrossRef]
  5. Miclăuş, T.; Valla, V.; Koukoura, A.; Nielsen, A.A.; Dahlerup, B.; Tsianos, G.I.; Vassiliadis, E. Impact of Design on Medical Device Safety. Ther. Innov. Regul. Sci. 2020, 54, 839–849. [Google Scholar] [CrossRef]
  6. Martinez-Marquez, D.; Terhaer, K.; Scheinemann, P.; Mirnajafizadeh, A.; Carty, C.P.; Stewart, R.A. Quality by Design for Industry Translation: Three-dimensional Risk Assessment Failure Mode, Effects, and Criticality Analysis for Additively Manufactured Patient-specific Implants. Eng. Rep. 2020, 2, e12113. [Google Scholar] [CrossRef]
  7. Frewen, H.; Brown, E.; Jenkins, M.; O’Donovan, A. Failure Mode and Effects Analysis in a Paperless Radiotherapy Department. J. Med. Imaging Radiat. Oncol. 2018, 62, 707–715. [Google Scholar] [CrossRef]
  8. DeRosier, J.; Stalhandske, E.; Bagian, J.P.; Nudell, T. Using Health Care Failure Mode and Effect Analysis: The VA National Center for Patient Safety’s Prospective Risk Analysis System. Jt. Comm. J. Qual. Improv. 2002, 28, 248–267. [Google Scholar] [CrossRef]
  9. Liu, H.C.; Zhang, L.J.; Ping, Y.J.; Wang, L. Failure Mode and Effects Analysis for Proactive Healthcare Risk Evaluation: A Systematic Literature Review. J. Eval. Clin. Pract. 2020, 26, 1320–1337. [Google Scholar] [CrossRef]
  10. Franklin, B.D.; Shebl, N.A.; Barber, N. Failure Mode and Effects Analysis: Too Little for Too Much? BMJ Qual. Saf. 2012, 21, 607–611. [Google Scholar] [CrossRef]
  11. Anjalee, J.A.L.; Rutter, V.; Samaranayake, N.R. Application of Failure Mode and Effect Analysis (FMEA) to Improve Medication Safety: A Systematic Review. Postgrad. Med. J. 2021, 97, 168–174. [Google Scholar] [CrossRef]
  12. Pintelon, L.; Di Nardo, M.; Murino, T.; Pileggi, G.; Vander Poorten, E. A New Hybrid MCDM Approach for RPN Evaluation for a Medical Device Prototype. Qual. Reliab. Eng. Int. 2021, 37, 2189–2213. [Google Scholar] [CrossRef]
  13. Southard, P.B.; Kumar, S.; Southard, C.A. A Modified Delphi Methodology to Conduct a Failure Modes Effects Analysis: A Patient-Centric Effort in a Clinical Medical Laboratory. Qual. Manag. Health Care 2011, 20, 131–151. [Google Scholar] [CrossRef] [PubMed]
  14. Martins, N.R.S.; Martinez, E.Z.; Simões, C.M.; Barach, P.R.; Carmona, M.J.C. Analyzing and Mitigating the Risks of Patient Harm during Operating Room to Intensive Care Unit Patient Handoffs. Int. J. Qual. Health Care 2025, 37, mzae114. [Google Scholar] [CrossRef] [PubMed]
  15. Parand, A.; Faiella, G.; Franklin, B.D.; Johnston, M.; Clemente, F.; Stanton, N.A.; Sevdalis, N. A Prospective Risk Assessment of Informal Carers’ Medication Administration Errors within the Domiciliary Setting. Ergonomics 2018, 61, 104–121. [Google Scholar] [CrossRef]
  16. Öhrn, A.; Ericsson, C.; Andersson, C.; Elfström, J. High Rate of Implementation of Proposed Actions for Improvement with the Healthcare Failure Mode Effect Analysis Method: Evaluation of 117 Analyses. J. Patient Saf. 2018, 14, 17–20. [Google Scholar] [CrossRef]
  17. Varndell, W.; Fry, M.; Elliott, D. Applying Real-Time Delphi Methods: Development of a Pain Management Survey in Emergency Nursing. BMC Nurs. 2021, 20, 149. [Google Scholar] [CrossRef]
  18. Ankam, V.S.S.; Hong, G.Y.; Fong, A.C. Design of a Mixed-Reality Application to Reduce Pediatric Medication Errors in Prehospital Emergency Care. Appl. Sci. 2024, 14, 8426. [Google Scholar] [CrossRef]
  19. Liu, H.C.; Liu, L.; Liu, N. Risk Evaluation Approaches in Failure Mode and Effects Analysis: A Literature Review. Expert Syst. Appl. 2013, 40, 828–838. [Google Scholar] [CrossRef]
  20. Shebl, N.A.; Franklin, B.D.; Barber, N. Failure Mode and Effects Analysis Outputs: Are They Valid? BMC Health Serv. Res. 2012, 12, 150. [Google Scholar] [CrossRef]
  21. Xu, A.Y.; Bhatnagar, J.; Bednarz, G.; Flickinger, J.; Arai, Y.; Vacsulka, J.; Feng, W.; Monaco, E.; Niranjan, A.; Lunsford, L.D.; et al. Failure Modes and Effects Analysis (FMEA) for Gamma Knife Radiosurgery. J. Appl. Clin. Med. Phys. 2017, 18, 152–168. [Google Scholar] [CrossRef]
  22. Liu, H.C.; Chen, X.Q.; Duan, C.Y.; Wang, Y.M. Failure Mode and Effect Analysis Using Multi-Criteria Decision Making Methods: A Systematic Literature Review. Comput. Ind. Eng. 2019, 135, 881–897. [Google Scholar] [CrossRef]
  23. Liu, H.C. FMEA Using Uncertainty Theories and MCDM Methods; Springer Nature: Singapore, 2016; ISBN 9789811014666. [Google Scholar]
  24. Legrand, J.; Javaux, A.; Ourak, M.; Wenmakers, D.; Vercauteren, T.; Deprest, J.; Ourselin, S.; Denis, K.; Vander Poorten, E. Handheld Active Add-on Control Unit for a Cable-Driven Flexible Endoscope. Front. Robot AI 2019, 6, 87. [Google Scholar] [CrossRef] [PubMed]
  25. Malshe, A.; Snowise, S.; Mann, L.K.; Boring, N.; Johnson, A.; Bebbington, M.W.; Moise, K.J.; Papanna, R. Preterm Delivery after Fetoscopic Laser Surgery for Twin–Twin Transfusion Syndrome: Etiology and Risk Factors. Ultrasound Obstet. Gynecol. 2017, 49, 612–616. [Google Scholar] [CrossRef] [PubMed]
  26. Khalil, A.; Perry, H.; Duffy, J.; Reed, K.; Baschat, A.; Deprest, J.; Hecher, K.; Lewi, L.; Lopriore, E.; Oepkes, D. Twin-Twin Transfusion Syndrome: Study Protocol for Developing, Disseminating, and Implementing a Core Outcome Set. Trials 2017, 18, 325. [Google Scholar] [CrossRef]
  27. Papanna, R.; Block-Abraham, D.; Mann, L.K.; Buhimschi, I.A.; Bebbington, M.; Garcia, E.; Kahlek, N.; Harman, C.; Johnson, A.; Baschat, A.; et al. Risk Factors Associated with Preterm Delivery after Fetoscopic Laser Ablation for Twin-Twin Transfusion Syndrome. Ultrasound Obstet. Gynecol. 2014, 43, 48–53. [Google Scholar] [CrossRef]
  28. Ahmad, M.A.; Ourak, M.; Gruijthuijsen, C.; Legrand, J.; Vercauteren, T.; Deprest, J.; Ourselin, S.; Poorten, E. Vander Design and Shared Control of a Flexible Endoscope with Autonomous Distal Tip Alignment. In Proceedings of the 2019 19th International Conference on Advanced Robotics, ICAR 2019, Belo Horizonte, Brazil, 2–6 December 2019; pp. 647–653. [Google Scholar]
  29. Thia, E.; Thain, S.; Yeo, G.S.H. Fetoscopic Laser Photocoagulation in Twin-to-Twin Transfusion Syndrome: Experience from a Single Institution. Singapore Med. J. 2017, 58, 321–326. [Google Scholar] [CrossRef]
  30. Winkler, S.M.; Harrison, M.R.; Messersmith, P.B. Biomaterials in Fetal Surgery. Biomater. Sci. 2019, 7, 3092–3109. [Google Scholar] [CrossRef]
  31. Sobaih, A.E.E.; Ritchie, C.; Jones, E. Consulting the Oracle? Applications of Modified Delphi Technique to Qualitative Research in the Hospitality Industry. Int. J. Contemp. Hosp. Manag. 2012, 24, 886–906. [Google Scholar] [CrossRef]
  32. Dindo, D.; Demartines, N.; Clavien, P.A. Classification of Surgical Complications: A New Proposal with Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann. Surg. 2004, 240, 205–213. [Google Scholar] [CrossRef]
  33. Guldentops, R. Development of a Framework for Efficient Risk Assessment of Surgical Robots and Advanced Surgical Instrumentation. Ph.D. Thesis, Katholieke Universiteit Leuven, Leuven, Belgium, 2017. [Google Scholar]
  34. Spencer, R.; Ambler, G.; Brodszki, J.; Diemert, A.; Figueras, F.; Gratacós, E.; Hansson, S.R.; Hecher, K.; Huertas-Ceballos, A.; Marlow, N.; et al. EVERREST Prospective Study: A 6-Year Prospective Study to Define the Clinical and Biological Characteristics of Pregnancies Affected by Severe Early Onset Fetal Growth Restriction. BMC Pregnancy Childbirth 2017, 17, 4–11. [Google Scholar] [CrossRef]
  35. Ford Motor Company. FMEA Handbook Version 4.1; Ford Motor Company: Dearborn, MI, USA, 2004. [Google Scholar]
  36. Kendall, M.G. A New Measure of Rank Correlation. Biometrika 1938, 30, 81. [Google Scholar] [CrossRef]
  37. Nathan, R.; Bhandari, S. Risk Assessment in Clinical Practice: A Framework for Decision-Making in Real-World Complex Systems. BJPsych Adv. 2024, 30, 53–63. [Google Scholar] [CrossRef]
  38. Subriadi, A.P.; Najwa, N.F. The Consistency Analysis of Failure Mode and Effect Analysis (FMEA) in Information Technology Risk Assessment. Heliyon 2020, 6, e03161. [Google Scholar] [CrossRef] [PubMed]
  39. Liu, P.; Shen, M.; Geng, Y. Risk Assessment Based on Failure Mode and Effects Analysis (FMEA) and WASPAS Methods under Probabilistic Double Hierarchy Linguistic Term Sets. Comput. Ind. Eng. 2023, 186, 109758. [Google Scholar] [CrossRef]
Figure 1. The new parts and components of the flexible fetoscope.
Figure 1. The new parts and components of the flexible fetoscope.
Applsci 15 06203 g001
Figure 2. Conceptual framework of a cascading Delphi method approach to data collection for advanced surgical instrument.
Figure 2. Conceptual framework of a cascading Delphi method approach to data collection for advanced surgical instrument.
Applsci 15 06203 g002
Figure 3. The new identified components of the flexible fetoscope.
Figure 3. The new identified components of the flexible fetoscope.
Applsci 15 06203 g003
Table 1. Ratings for severity with respect to the mother [33].
Table 1. Ratings for severity with respect to the mother [33].
ScoreScaleDescription
1Grade IWithout the need for pharmacological treatment
2Grade IIRequiring pharmacological treatment
3Grade IIIaIntervention not under general anesthesia
4Grade IIIbIntervention under general anesthesia
5Grade IVaSingle organ dysfunction (including dialysis)
6Grade IVbMultiorgan dysfunction
7Grade VDeath of the patient
Table 2. Ratings for severity with respect to the fetus [33].
Table 2. Ratings for severity with respect to the fetus [33].
ScoreScaleDescription
1Low dangerDoes not endanger the fetuses in any way.
2Moderate dangerHarm to a fetal organ
3DangerousHarm to a fetal organ which requires future intervention
4Very dangerousHarm to a fetal organ which is life-threatening
5Extremely dangerousFetal death
Table 3. Ratings for probability of occurrence [33].
Table 3. Ratings for probability of occurrence [33].
ScoreScaleDescription
1Very lowFailure happens very infrequently (1/10,000–fewer)
2LowFailure happens rarely (1/1000–1/10,000)
3ModerateFailure happens occasionally (1/100–1/1000)
4HighFailure happens often (1/10–1/100)
5Very highFailure is unavoidable or very possible (1–1/10)
Table 4. Ratings for detectability [33].
Table 4. Ratings for detectability [33].
ScoreScaleDescription
1Very highFailure is easily detected
2HighFailure is detected frequently
3ModerateFailure is detected occasionally by double checking
4LowFailure is rarely detected
5Very lowFailure is almost never detected
Table 5. Information of 11 experts.
Table 5. Information of 11 experts.
TopicNumber
1. Occupation11 (100%)
Engineer from KU Leuven, Belgium (producer)6 (55%)
Obstetric surgeon from University in Thailand (User)5 (45%)
2. Position11 (100%)
Medical teacher5 (45%)
PhD student4 (37%)
Research engineer1 (9%)
Postdoctoral researcher1 (9%)
3. Specialization11 (100%)
Maternal–fetal medicine5 (46%)
Minimally invasive surgery2 (18%)
Electromechanical engineering1 (9%)
Medical robotic and control2 (18%)
Mechanical engineering1 (9%)
4. Experience11 (100%)
>5 years5 (44%)
2–5 years3 (28%)
≤2 years3 (28%)
Table 6. Potential failure modes of the new part of the flexible fetoscope.
Table 6. Potential failure modes of the new part of the flexible fetoscope.
IDPotential Failure Modes (26)Number (%) *
1Handle—6 (23%)
1.1.1Slider breaks4 (36%)
1.2.1Applying excessive force on wire8 (73%)
1.3.1Wire suddenly snaps4 (36%)
1.4.1Excessive air pressure3 (27%)
1.4.2Air leaks within the handle6 (55%)
1.4.3Unfiltered or unclean air supply1 (9%)
2Flexible segment—7 (27%)
2.1.1Bending or tip positioning issues4 (36%)
2.1.2Permanent plastic deformation due to excessive forces1 (9%)
2.2.1Laser fiber snaps—during ablation3 (27%)
2.2.2Preventing ablation of laser fiber2 (18%)
2.3.1Wire suddenly snaps1 (9%)
2.4.1Electrical wire snaps/ disconnects (due to repetitive large bending)1 (9%)
2.5.1Leakage of irrigation fluid and contact with bare electrical wire1 (9%)
3Tip—13 (50%)
3.1.1The tip breaks during use1 (9%)
3.2.1Damage of the camera6 (55%)
3.2.2Camera detachment2 (18%)
3.3.1Light-source failure3 (27%)
3.3.2Heating or thermal injury1 (9%)
3.4.1Wire suddenly snaps1 (9%)
3.5.1Fluid contact with bare electrical wires2 (18%)
3.6.1Loosening of the tube end sleeve1 (9%)
3.7.1Cracking of the glue1 (9%)
3.7.2Loss of particles (debris) during use inside the patient1 (9%)
3.7.3Dislodging of the glue2 (18%)
3.7.4Heating, glue melting6 (55%)
3.8.1Contamination of the fetoscope1 (9%)
* Total 11 FMEA experts.
Table 7. Illustrative examples of data collected using the cascading Delphi FMEA method.
Table 7. Illustrative examples of data collected using the cascading Delphi FMEA method.
IDPotential Failure ModesMain EffectsPotential
Failure Effects
(S)
S
Score
Potential
Failure Causes
(O)
O
Score
Detectability (D)D
Score
1. Handle
1.1 Slider
1.1.1Slider breaks
1.1.1A1 MotherDevice configuration issues1Slider or handle mechanism issues1Visual observation1
1.1.1B1 FetusesDevice configuration issues2Slider or handle mechanism issues2Visual observation1
1.1.1A2 MotherDevice configuration issues1User errors or misuse2Visual observation1
1.1.1B2 FetusesDevice configuration issues2User errors or misuse2Visual observation1
Table 8. Weights of criteria.
Table 8. Weights of criteria.
CriteriaWeights
Severity0.265981
Occurrence0.233806
Detectability0.500213
Total1
Table 9. Top 20% risk and severity scores ranked by Pareto principle.
Table 9. Top 20% risk and severity scores ranked by Pareto principle.
RankIDSODRisk ScoreRankIDSODRisk Score
13.8.1A37150.927532.5.1B93150.737
23.7.2A14250.896543.5.1B103150.737
33.7.2B64250.896553.5.1B123150.737
43.7.3A14250.896563.5.1B133150.737
53.7.3B54250.896573.5.1B143150.737
63.8.1A14.3332.3334.3330.849583.5.1B153150.737
73.7.1B33250.848593.5.1B163150.737
83.7.1B63250.848603.5.1B173150.737
93.7.2A53250.848613.5.1B35230.722
103.7.3A43250.848623.7.1A15230.722
113.7.2A44.1431.7144.7140.844633.8.1A24.251.53.750.720
121.4.3A24340.838643.7.3B42.4441.8894.3330.717
133.8.1B54340.838653.7.2A35140.708
143.8.1B45150.826662.5.1B631.66740.707
153.5.1A27230.823671.2.1B23520.696
161.4.3B23.5340.818683.5.1A841.53.50.686
173.8.1B13.52.3334.3330.815692.2.2A34230.681
183.7.3A33.8891.8894.2220.79703.3.2A24230.681
193.7.1B52.2250.787713.3.2A54230.681
202.5.1A104150.785723.3.2A64230.681
212.5.1A54150.785733.7.1B14230.681
222.5.1A74150.785743.7.3B34230.681
232.5.1A84150.785752.5.1A35.522.50.679
242.5.1A94150.785762.5.1B74140.668
253.5.1A114150.785773.5.1B114140.668
263.5.1A124150.785783.5.1B54140.668
273.5.1A134150.785793.7.2B34140.668
283.5.1A144150.785803.5.1A32240.654
293.5.1A154150.785813.5.1B22240.654
303.5.1A164150.785823.5.1B72240.654
313.5.1A94150.785833.6.1B62240.654
323.8.1B24150.785843.2.2A45130.610
333.7.1B22.66724.6670.78851.2.1A34.51.752.250.575
343.7.2B42.8571.7144.7140.78862.2.1A1251.520.526
353.7.2A74240.779871.2.1A15120.458
363.7.2A84240.779883.1.1A115120.458
373.7.2A94240.779892.2.1A105.3331.3331.6670.457
381.4.3A12250.771903.3.2A75.51.51.50.453
393.7.1A22250.771913.3.2B84.51.51.50.411
403.7.1A52250.771923.4.1A64.41.21.20.307
413.7.1A62250.771931.4.2A16110.303
423.7.2B12250.771941.4.2A26110.303
433.7.3B12250.771952.2.1A116110.303
442.5.1A66140.753962.2.1A76110.303
453.5.1A106140.753972.2.1A86110.303
463.5.1A56140.753982.2.1A96110.303
472.5.1A43.6671.66740.741991.3.1A45110.258
483.7.1A32.28624.5710.741002.2.1B65110.258
492.5.1B103150.7371012.3.1A45110.258
502.5.1B113150.7371022.3.1A55110.258
512.5.1B53150.7371032.3.1A65110.258
522.5.1B83150.7371043.4.1A85110.258
Table 10. Kendall’s Tau correlation matrix among scenario weightings.
Table 10. Kendall’s Tau correlation matrix among scenario weightings.
No.Scenario 1Scenario 2Scenario 3Scenario 4
Scenario 11.0000.5550.8380.552
Scenario 20.5551.0000.6790.439
Scenario 30.8380.6791.0000.685
Scenario 40.5520.4390.6851.000
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Phokee, W.; Chaiklieng, S.; Boriwan, P.; Phoka, T.; Vanoirbeek, J.; Chatpun, S. A Cascading Delphi Method-Based FMEA Risk Assessment Framework for Surgical Instrument Design: A Case Study of a Fetoscope. Appl. Sci. 2025, 15, 6203. https://doi.org/10.3390/app15116203

AMA Style

Phokee W, Chaiklieng S, Boriwan P, Phoka T, Vanoirbeek J, Chatpun S. A Cascading Delphi Method-Based FMEA Risk Assessment Framework for Surgical Instrument Design: A Case Study of a Fetoscope. Applied Sciences. 2025; 15(11):6203. https://doi.org/10.3390/app15116203

Chicago/Turabian Style

Phokee, Wipharat, Sunisa Chaiklieng, Pornpimon Boriwan, Thanathorn Phoka, Jeroen Vanoirbeek, and Surapong Chatpun. 2025. "A Cascading Delphi Method-Based FMEA Risk Assessment Framework for Surgical Instrument Design: A Case Study of a Fetoscope" Applied Sciences 15, no. 11: 6203. https://doi.org/10.3390/app15116203

APA Style

Phokee, W., Chaiklieng, S., Boriwan, P., Phoka, T., Vanoirbeek, J., & Chatpun, S. (2025). A Cascading Delphi Method-Based FMEA Risk Assessment Framework for Surgical Instrument Design: A Case Study of a Fetoscope. Applied Sciences, 15(11), 6203. https://doi.org/10.3390/app15116203

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop